Neutrophils exacerbate acetaminophen-induced liver injury by producing cytotoxic interferon-γ
Hao Wu,Chunqing Guo,Zheng Liu,Jinyang Cai,Chong Wang,Huanfa Yi,Arun Sanyal,Puneet Puri,Huiping Zhou,Xiang-Yang Wang
DOI: https://doi.org/10.1016/j.intimp.2023.110734
IF: 5.714
2023-10-01
International Immunopharmacology
Abstract:BACKGROUND: Drug (e.g., acetaminophen, APAP)-associated hepatotoxicity is the major cause of acute liver failure. Emerging evidence shows that initial tissue damage caused by APAP triggers molecular and cellular immune responses, which can modulate the severity of hepatoxicity. The pro-inflammatory and cytotoxic cytokine interferon (IFN)-γ has been reported as a key molecule contributing to APAP-induced liver injury (AILI). However, its cellular source remains undetermined.RESULTS: In the current study, we show that elevation of serum IFN-γ in patients with drug hepatotoxicity correlates with disease severity. Neutralization of IFN-γ in a mouse model of AILI effectively reduces hepatotoxicity. Strikingly, we reveal that IFN-γ is expressed primarily by hepatic neutrophils, not by conventional immune cells with known IFN-γ-producing capability, e.g., CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, natural killer cells, or natural killer T cells. Upon encountering APAP-injured hepatocytes, neutrophils secrete cytotoxic IFN-γ further causing cell stress and damage, which can be abrogated in the presence of blocking antibodies for IFN-γ or IFN-γreceptor. Furthermore, removal of neutrophils in vivo substantially decreases hepatic IFN-γ levels concomitantly with reduced APAP hepatotoxicity, whereas adoptive transfer of IFN-γ-producing neutrophils confers IFN-γ<sup>-/-</sup> mice susceptibility to APAP administration.CONCLUSIONS: Our findings uncover a novel mechanism of neutrophil action in promoting AILI and provide new insights into immune modulation of the disease pathogenesis.
pharmacology & pharmacy,immunology